No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 4.2x · 10Y median 4.4x · 42nd percentile · as of Oct 6, 2026
Annual revenue · last 3 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-01-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-01-30.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-01-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T20:53:36.700Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Wealthfront Corporation (WLTH) stock was $10.55 as of Oct 6, 2026, 4:00 PM EDT, down 0.66% from the previous close.
Wealthfront Corporation operates as a privately held asset management firm. While primarily serving individual investors, its client base also extends to high-net-worth individuals, charitable organizations, and corporate entities.
Software - Application · Redwood City, CA
Next Earnings Date
Jan 12, 2027
98 days away
EPS Estimate
0.08
Revenue Est.
$94.36M
Last Quarter Results
EPS
$0.18
vs Estimate
$0.16
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1WLTH | $1.58B | $10.55 | -0.66% | N/A | N/A | N/A | N/A |
| 2PICS | $1.61B | $12.46 | +7.23% | N/A | N/A | N/A | vs WLTH |
| 3MQ | $1.62B | $16.55 | -2.82% | -16.61% | -27.24% | N/A | vs WLTH |
| 4PRGS | $1.53B | $37.20 | -0.04% | -19.30% | -4.90% | +4.16% | vs WLTH |
| 5CNXC | $1.52B | $24.84 | -3.98% | -43.66% | -30.54% | N/A | vs WLTH |
| 6EVCM | $1.64B | $9.27 | +2.21% | -17.69% | -12.23% | N/A | vs WLTH |
forward FY estimate
29.31
$91.87M
vs Estimate
$91.53M
Consensus Rating
Based on 7 analysts
Average Price Target
$12.11
+14.8% upside
Low
$10.00
Current
$10.55
High
$17.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.06 | $0.08 | $0.09 | 3 |
| Quarter ending Jan 2027 | $0.08 | $0.10 | $0.12 | 3 |
| Quarter ending Apr 2027 | $0.10 | $0.10 | $0.11 | 1 |
| Quarter ending Jul 2027 | $0.11 | $0.11 | $0.11 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.32 | $0.36 | $0.40 | 4 |
| FY 2028 | $0.45 | $0.48 | $0.50 | 4 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $93.24M | $94.36M | $96.53M | 4 |
| Quarter ending Jan 2027 | $96.92M | $98.08M | $100.34M | 4 |
| Quarter ending Apr 2027 | $99.22M | $100.41M | $102.72M | 2 |
| Quarter ending Jul 2027 | $106.02M | $107.29M | $109.76M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jan 31, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $363.49M | $374.89M | $389.66M | 5 |
| FY 2028 | $426.14M | $439.50M | $456.83M | 5 |
